Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BECTON DICKINSON & COBDX · Entity 2498 | Director | January 27, 2026 | January 29, 2026 |
| Fortrea Holdings Inc.FTRE · Entity 4623 | Director | February 21, 2025 | February 25, 2025 |
| MARAVAI LIFESCIENCES HOLDINGS, INC.MRVI · Entity 4291 | Director | May 26, 2026 | May 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BECTON DICKINSON & CO
Report date January 27, 2026 · Filed January 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,423 |
Reported balance
After 2026-01-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-01-27 · Grant · Acquired 1,098 · Balance 10,423 F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2: Includes units acquired through dividend investment since the last report filed by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
F2: Includes units acquired through dividend investment since the last report filed by the reporting person.
Fortrea Holdings Inc.
Report date February 21, 2025 · Filed February 25, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,636 |
Reported balance
After 2025-02-21 transaction · row 1
1 source rowRow 1 · 2025-02-21 · Exercise / conversion · Acquired 7,282 · Balance 13,636 F1: The Management Development and Compensation Committee of Board of Directors approved, immediately upon the Reporting Person's resignation from the Board of Directors, accelerated vesting of 7,282 Restricted Stock Units that were otherwise scheduled to vest on May 18, 2025. These Restricted Stock Units converted into common stock on a one-for-one basis |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-02-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-02-21 · Exercise / conversion · Disposed 7,282 · Balance 0 F2: Each Restricted Stock Unit represents the right to receive, at settlement, one share of Fortrea Holdings Inc. Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock. F1: The Management Development and Compensation Committee of Board of Directors approved, immediately upon the Reporting Person's resignation from the Board of Directors, accelerated vesting of 7,282 Restricted Stock Units that were otherwise scheduled to vest on May 18, 2025. These Restricted Stock Units converted into common stock on a one-for-one basis |
Filing footnotes · ownership attribution and instrument terms
F1: The Management Development and Compensation Committee of Board of Directors approved, immediately upon the Reporting Person's resignation from the Board of Directors, accelerated vesting of 7,282 Restricted Stock Units that were otherwise scheduled to vest on May 18, 2025. These Restricted Stock Units converted into common stock on a one-for-one basis
F2: Each Restricted Stock Unit represents the right to receive, at settlement, one share of Fortrea Holdings Inc. Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock.
MARAVAI LIFESCIENCES HOLDINGS, INC.
Report date May 26, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 412,183 |
Reported balance
After 2026-05-26 transaction · row 1
1 source rowRow 1 · 2026-05-26 · Grant · Acquired 46,293 · Balance 412,183 F1: Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on May 26, 2026, which vest in full upon the earlier of one year from the date of grant or the date of the 2027 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on May 26, 2026, which vest in full upon the earlier of one year from the date of grant or the date of the 2027 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
VARIAN MEDICAL SYSTEMS INC
Report date December 02, 2020 · Filed April 16, 2021
Section 16 reporting ended · disclosed 2021-04-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,771 |
Reported balance
After 2020-12-02 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2020-12-02 · Gift · Disposed 277 · Balance 12,771 |
| Common StockSEC Table I · non-derivative | Direct | 13,826 |
Reported balance
After 2021-04-15 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2021-04-15 · Gift · Disposed 170 · Balance 13,826 |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2021-04-15 · Disposition to issuer · Disposed 13,826 · Balance 0 F1: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-04-15 · Disposition to issuer · Disposed 1,022 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.
F2: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
F3: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2026 Filed May 28, 2026 22:26 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 46,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001210525-26-000001 · wk-form4_1780007192.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 412,183 F1 · shares: Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on May 26, 2026, which vest in full upon the earlier of one year from the date of grant or the date of the 2027 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 14:57 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 1,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-004017 · wk-form4_1769698638.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,423 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes units acquired through dividend investment since the last report filed by the reporting person. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 22:24 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 231,481 | $2.16 | $499,998.96 |
DisclosureSEC source: 0001823239-25-000083 · wk-form4_1750285464.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,890 F1 · shares: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon Vesting. One-half (1/2) of the RSUs shall be fully vested upon the date of grant, and the remaining RSUs shall vest on May 22, 2026, the one-year anniversary of the date of the 2025 Annual Meeting of Shareholders of the Company. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 22:12 UTC | Fortrea Holdings Inc. FTRE · Entity 4623 | Exercise / conversionRestricted Stock Unit · Derivative | 7,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006646 · form4.xml · derivative · entry 2 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of Fortrea Holdings Inc. Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock. F1 · derivative.exercise_date: The Management Development and Compensation Committee of Board of Directors approved, immediately upon the Reporting Person's resignation from the Board of Directors, accelerated vesting of 7,282 Restricted Stock Units that were otherwise scheduled to vest on May 18, 2025. These Restricted Stock Units converted into common stock on a one-for-one basis F1 · derivative.expiration_date: The Management Development and Compensation Committee of Board of Directors approved, immediately upon the Reporting Person's resignation from the Board of Directors, accelerated vesting of 7,282 Restricted Stock Units that were otherwise scheduled to vest on May 18, 2025. These Restricted Stock Units converted into common stock on a one-for-one basis Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 22:12 UTC | Fortrea Holdings Inc. FTRE · Entity 4623 | Exercise / conversionCommon Stock | 7,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006646 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Management Development and Compensation Committee of Board of Directors approved, immediately upon the Reporting Person's resignation from the Board of Directors, accelerated vesting of 7,282 Restricted Stock Units that were otherwise scheduled to vest on May 18, 2025. These Restricted Stock Units converted into common stock on a one-for-one basis Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 21:02 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 930 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-001304 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,170 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 21:46 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 134,409 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001823239-24-000130 · wk-form4_1734472004.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,409 F1 · price: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon Vesting. One-third (1/3) of the RSUs shall be fully vested upon the date of grant, and the remaining RSUs shall vest in two equal installments on the date of the 2025 Annual Meeting of Shareholders of the Company (the "2025 Annual Meeting Date") and the one-year anniversary of the 2025 Annual Meeting Date. Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 21:22 UTC | Fortrea Holdings Inc. FTRE · Entity 4623 | Exercise / conversionRestricted Stock Unit · Derivative | 6,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-020749 · form4.xml · derivative · entry 2 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,282 Underlying: Common Stock · 6,354 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Fortrea Holdings Inc. Common Stock. F3 · derivative.exercise_date: The RSUs vested on July 18, 2024. F3 · derivative.expiration_date: The RSUs vested on July 18, 2024. F4 · balance_after: This number reflects the aggregate number of RSUs held by the reporting person. Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 21:22 UTC | Fortrea Holdings Inc. FTRE · Entity 4623 | Exercise / conversionCommon Stock | 6,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-020749 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,354 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Fortrea Holdings Inc. Common Stock. F2 · balance_after: This number reflects the aggregate amount of Common Stock held by the reporting person. Read SEC document |
| May 14, 2024 Filed May 16, 2024 20:33 UTC | Fortrea Holdings Inc. FTRE · Entity 4623 | GrantRestricted Stock Unit · Derivative | 7,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015687 · form4.xml · derivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,636 Underlying: Common Stock · 7,282 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Fortrea Holdings Inc. Common Stock. F2 · derivative.exercise_date: Represents a RSU award that vests in its entirety twelve months after May 14, 2024, subject to the Reporting Person's continued service as a director. F2 · derivative.expiration_date: Represents a RSU award that vests in its entirety twelve months after May 14, 2024, subject to the Reporting Person's continued service as a director. F3 · balance_after: This number reflects the aggregate number of RSUs held by the reporting person. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 21:14 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-001301 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,124 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| July 18, 2023 Filed Jul 19, 2023 21:18 UTC | Fortrea Holdings Inc. FTRE · Entity 4623 | GrantRestricted Stock Unit · Derivative | 6,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-021049 · form4.xml · derivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,354 Underlying: Common Stock · 6,354 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Fortrea Holdings Inc. Common Stock. F2 · derivative.exercise_date: The RSUs vest in full on July 18, 2024, subject to the Reporting Person's continued service as a director. F2 · derivative.expiration_date: The RSUs vest in full on July 18, 2024, subject to the Reporting Person's continued service as a director. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 23:03 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 848 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-001431 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,992 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 18:20 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-001581 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,216 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 20:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Disposition to issuerRestricted Stock Units · Derivative | 1,022 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-013928 · form4.xml · derivative · entry 4 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,022 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · price: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 20:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Disposition to issuerCommon Stock | 13,826 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-013928 · form4.xml · nonDerivative · entry 3 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 20:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 170 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-013928 · form4.xml · nonDerivative · entry 2 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,826 Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 19:04 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 1,225 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006363 · form4.xml · derivative · entry 3 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,225 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 19:04 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,225 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006363 · form4.xml · nonDerivative · entry 2 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 08:29 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 1,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005600 · form4.xml · derivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,022 Underlying: Common Stock · 1,022 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 13:53 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 829 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-21-000006 · edgar.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,384 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 02, 2020 Filed Apr 16, 2021 20:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 277 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-013928 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,771 Read SEC document |
| May 22, 2020 Filed Oct 26, 2020 15:49 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-027508 · form5.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,048 Read SEC document |
| May 22, 2020 Filed Feb 17, 2021 19:04 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006363 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,048 Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 19:04 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 1,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006573 · form4.xml · derivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,225 Underlying: Common Stock · 1,225 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 19:36 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 1,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006203 · form4.xml · derivative · entry 3 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,243 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · derivative.exercise_date: The restricted stock units vest on the earlier of February 15, 2020, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F3 · derivative.expiration_date: The restricted stock units vest on the earlier of February 15, 2020, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 19:36 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006203 · form4.xml · nonDerivative · entry 2 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Feb 4, 2020 filing balance of 9,915 accurately reflected a gift of 2,400 shares made on October 25, 2019. Gift was not listed in table I of the filing. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:06 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionDeferred Stock Units · Derivative | 1,990 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-005159 · form4.xml · derivative · entry 2 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,990 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit represents the right to receive one share of VAR common stock. F1 · price: Each Deferred Stock Unit represents the right to receive one share of VAR common stock. F2 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 10, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change in control. F2 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 10, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change in control. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:06 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,990 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-005159 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,905 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit represents the right to receive one share of VAR common stock. Read SEC document |
| February 04, 2020 Filed Feb 4, 2020 19:25 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 5,651 | $0.00 Strike: $61.98 | $0.00 |
DisclosureSEC source: 0001127602-20-003666 · form4.xml · derivative · entry 3 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,651 shares Expires 2020-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. Read SEC document |
| February 04, 2020 Filed Feb 4, 2020 19:25 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 5,651 | $142.41 | $804,758.91 |
DisclosureSEC source: 0001127602-20-003666 · form4.xml · nonDerivative · entry 2 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,915 Read SEC document |
| February 04, 2020 Filed Feb 4, 2020 19:25 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 5,651 | $61.98 | $350,248.98 |
DisclosureSEC source: 0001127602-20-003666 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 18:54 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 765 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000021 · edgar.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,555 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| November 14, 2019 Filed Feb 18, 2020 19:36 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006203 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,855 Read SEC document |
| June 11, 2019 Filed Nov 1, 2019 13:55 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 120 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-031437 · form5.xml · nonDerivative · entry 9 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,315 Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 18:33 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 1,243 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007276 · form4.xml · derivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,243 Underlying: Common Stock · 1,243 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 15, 2020, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 15, 2020, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:49 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionDeferred Stock Units · Derivative | 2,384 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006160 · form4.xml · derivative · entry 4 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,990 Underlying: Common Stock · 2,384 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Deferred Stock Unit represents the right to receive one share of VAR common stock. F4 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 10, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change in control. F4 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 10, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change in control. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:49 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 2,384 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006160 · form4.xml · nonDerivative · entry 2 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2019 Filed Feb 14, 2019 20:49 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 1,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006160 · form4.xml · derivative · entry 3 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,441 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 9, 2019, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 9, 2019, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 11, 2019 Filed Feb 14, 2019 20:49 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006160 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 19:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 5,651 | $0.00 Strike: $57.27 | $0.00 |
DisclosureSEC source: 0001127602-19-003128 · form4.xml · derivative · entry 5 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,651 shares Expires 2019-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 19:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 5,651 | $130.15 | $735,477.65 |
DisclosureSEC source: 0001127602-19-003128 · form4.xml · nonDerivative · entry 4 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,476 Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 19:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 5,651 | $57.27 | $323,632.77 |
DisclosureSEC source: 0001127602-19-003128 · form4.xml · nonDerivative · entry 3 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,127 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 15:54 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 923 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000009 · edgar.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,790 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| November 29, 2018 Filed Jan 30, 2019 19:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 330 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-003128 · form4.xml · nonDerivative · entry 2 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,476 Read SEC document |
| October 30, 2018 Filed Jan 30, 2019 19:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 745 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-003128 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,806 Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 21:03 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionDeferred Stock Units · Derivative | 1,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-006215 · form4.xml · derivative · entry 2 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,374 Underlying: Common Stock · 1,952 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit represents the right to receive one share of VAR common stock. F2 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 13, 2015. Vested shares will be delivered to the reporting person the earlier of three years from the grant date, or termination/retirement date. F2 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 13, 2015. Vested shares will be delivered to the reporting person the earlier of three years from the grant date, or termination/retirement date. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 21:03 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-006215 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2018 Filed Feb 12, 2018 19:52 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 1,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005258 · form4.xml · derivative · entry 2 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,441 Underlying: Common Stock · 1,441 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 9, 2019, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 9, 2019, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 08, 2018 Filed Feb 12, 2018 19:52 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005258 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,599 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.